Related Experiment Videos

Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo

Yuning Xiong1, Sean C Dowdy, Karl C Podratz

  • 1Department of Obstetrics and Gynecology, Division of Endocrinology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

Cancer Research
|April 5, 2005
PubMed
Summary

Histone deacetylase (HDAC) inhibitor trichostatin A (TSA) reduces DNA methyltransferase 3B (DNMT3B) expression and de novo DNA methylation. This epigenetic regulation by TSA offers new insights for cancer therapy.

Related Concept Videos